Oral corticosteroids for asthma or COPD were dispensed to 2.6% of Norwegians aged 7 years or over in 2004-5

Primary Care Respiratory Journal

Volumn 20, Issue 3, 2011, Pages 332-335

  Selstad, Gro Marie ^a   Melbye, Hasse ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTERIOD PLUS LONG ACTING BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; PREDNISOLONE; SHORT ACTING DRUG; UNCLASSIFIED DRUG;

ADULT; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCRIPTION; PREVALENCE; REIMBURSEMENT; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CHILD; FEMALE; HUMANS; MALE; NORWAY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 80052558190     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2011.00043     Document Type: Letter

References (10)

1. Tirumalasetty J, Grammer LC. Asthma, surgery and general anaesthesia: a review. J Asthma 2006;43(4):251-4. http://dx.doi.org/10.1080/02770900600643162
2. Al-alami AA, Zestos MM, Baraka AS. Pediatric laryngospasm: prevention and treatment. Curr Opin Anaesthesiol 2009;22(3):388-95. http://dx.doi.org/10.1097/ACO.0b013e32832972f3
3. Bremerich DH, Anesthesia in bronchial asthma. Anasthesiol Intensivmed Notfallmed Schmerzther 2000;35(9):545-58. http://dx.doi.org/10.1055/s-2000-7091
4. Global Initiative for Asthma. Global Strategy for asthma Management and Prevention. Updated 2009 (www.ginasthma.com)
5. Smetana GW. Preoperative pulmonary evaluation. N Engl J Med 1999;340:937-44. http://dx.doi.org/10.1056/NEJM199903253401207
6. Liccardi G, Salzillo A, Piccolo A, De Napoli I, D'Amato G. The risk of bronchospasm in asthmatics undergoing general anaesthesia and/or intravascular administration of radiographic contrast media. Physiopathology and clinical/functional evaluation. Eur Ann Allergy Clin Immunol 2010;43:167-73
7. Liccardi G, Salzillo A, De Blasio F, D'Amato G. Control of asthma for reducing the risk of bronchospasm in asthmatics undergoing general anestesia and/or intravascular administration of radiographic contrast media. Curr Med Res Opin 2009;25(7):1621-30. http://dx.doi.org/10.1185/03007990903010474
8. Liccardi G, Salzillo A, D'Amato G. Il rischio di broncospasmo nei pazienti asmatici da sottoporre ad anestesia generale o a somministrazione endovascolare di mezzi di contrasto diagnostici. Aspetti fisiopatologici, clinici e valutativi. Rass Patol App Respir 2007;22(6):407-14.
9. Liccardi G, Lobefalo G, Di Florio E, et al. on behalf of C.H.R.A.i.A. P (Cardarelli Hospital Radio Contrast Media and Anesthetic induced Anaphylaxis Prevention) Working Group. Strategies for prevention of asthmatic, anaphylactic and anaphylactoid reactions during the administration of anaesthetics and / or contrast media (CM). J Investig Allergol Clin Immunol 2008;18:1-11.
10. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113(1):59-65. http://dx.doi.org/10.1016/j.jaci.2003.09.008